340 related articles for article (PubMed ID: 29329301)
1. Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey.
Holmes CB; Sikazwe I; Sikombe K; Eshun-Wilson I; Czaicki N; Beres LK; Mukamba N; Simbeza S; Bolton Moore C; Hantuba C; Mwaba P; Phiri C; Padian N; Glidden DV; Geng E
PLoS Med; 2018 Jan; 15(1):e1002489. PubMed ID: 29329301
[TBL] [Abstract][Full Text] [Related]
2. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
[TBL] [Abstract][Full Text] [Related]
3. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
[TBL] [Abstract][Full Text] [Related]
6. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
[TBL] [Abstract][Full Text] [Related]
7. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
[TBL] [Abstract][Full Text] [Related]
8. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
9. Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
Mody A; Sikazwe I; Czaicki NL; Wa Mwanza M; Savory T; Sikombe K; Beres LK; Somwe P; Roy M; Pry JM; Padian N; Bolton-Moore C; Holmes CB; Geng EH
PLoS Med; 2018 Jun; 15(6):e1002574. PubMed ID: 29870531
[TBL] [Abstract][Full Text] [Related]
10. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis.
Van Cutsem G; Ford N; Hildebrand K; Goemaere E; Mathee S; Abrahams M; Coetzee D; Boulle A
PLoS One; 2011 Feb; 6(2):e14684. PubMed ID: 21379378
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
[TBL] [Abstract][Full Text] [Related]
12. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.
Geng EH; Glidden DV; Emenyonu N; Musinguzi N; Bwana MB; Neilands TB; Muyindike W; Yiannoutsos CT; Deeks SG; Bangsberg DR; Martin JN
Trop Med Int Health; 2010 Jun; 15 Suppl 1(Suppl 1):63-9. PubMed ID: 20586962
[TBL] [Abstract][Full Text] [Related]
13. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis.
Mody A; Glidden DV; Eshun-Wilson I; Sikombe K; Simbeza S; Mukamba N; Somwe P; Beres LK; Pry J; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
Clin Infect Dis; 2020 Dec; 71(10):e561-e570. PubMed ID: 32173743
[TBL] [Abstract][Full Text] [Related]
15. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
Kaplan SR; Oosthuizen C; Stinson K; Little F; Euvrard J; Schomaker M; Osler M; Hilderbrand K; Boulle A; Meintjes G
PLoS Med; 2017 Nov; 14(11):e1002407. PubMed ID: 29112692
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
Bolton-Moore C; Mubiana-Mbewe M; Cantrell RA; Chintu N; Stringer EM; Chi BH; Sinkala M; Kankasa C; Wilson CM; Wilfert CM; Mwango A; Levy J; Abrams EJ; Bulterys M; Stringer JS
JAMA; 2007 Oct; 298(16):1888-99. PubMed ID: 17954540
[TBL] [Abstract][Full Text] [Related]
17. Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand.
Teeraananchai S; Kerr SJ; Puthanakit T; Bunupuradah T; Ruxrungtham K; Chaivooth S; Law MG; Chokephaibulkit K
J Pediatr; 2017 Sep; 188():210-216.e1. PubMed ID: 28606372
[TBL] [Abstract][Full Text] [Related]
18. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART.
Amanzi P; Michelo C; Simoonga C; Dambe R; Chongwe G
Pan Afr Med J; 2016; 24():144. PubMed ID: 27642482
[TBL] [Abstract][Full Text] [Related]
19. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
[TBL] [Abstract][Full Text] [Related]
20. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
Schöni-Affolter F; Keiser O; Mwango A; Stringer J; Ledergerber B; Mulenga L; Bucher HC; Westfall AO; Calmy A; Boulle A; Chintu N; Egger M; Chi BH; ;
PLoS One; 2011; 6(12):e27919. PubMed ID: 22205933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
